Clincosm LogoSign in Get a demo

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03668769
Collaborator
National Cancer Institute (NCI) (NIH)
19
Enrollment
1
Location
1
Arm
69.2
Anticipated Duration (Months)
0.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This trial studies how well a mobile smartphone application called Quitting Schedule works in helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a computer-based initiative that offered state of-the-art smoking cessation treatment and counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for non-patients to find information regarding smoking cessation advice and treatments. Quitting Schedule may help participants to quit smoking.

Condition or Disease Intervention/Treatment Phase
  • Other: Internet Mobile Technology
  • Other: Interview
  • Other: Questionnaire Administration
  • Behavioral: Smoking Cessation Intervention
 N/A

Detailed Description

PRIMARY OBJECTIVES:

  1. To adapt the internal algorithms of the scheduled reduced smoking approach in Computer Assisted Stop Smoking Intervention for the World Wide Web (WebCASSI) into a smartphone application (app): Quitting Schedule.

  2. Once the smartphone app is developed, a pretesting phase with smoker seeking care at MDACC Tobacco Treatment Program or another community service such as Equality Texas, Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Advisory Board of the City of Houston, Montrose Center, Avenue 360 and Lesbian Health Initiative will follow.

  3. To culturally and linguistically adapt Quitting Schedule app into Spanish language.

  4. To implement a feasibility trial in IDC (Colombia), INCan (Mexico), and INEN (Peru).

OUTLINE:

AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.

AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
19 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Project Quitting Schedule
Actual Study Start Date :
Mar 27, 2017
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prevention (smoking reduction, Quitting Schedule mobile app)

AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule. AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.

Other: Internet Mobile Technology
Use Quitting Schedule mobile smartphone app
Other Names:
  • www-mobile

    • Other: Interview
    Ancillary studies

    Other: Questionnaire Administration
    Ancillary studies

    Behavioral: Smoking Cessation Intervention
    Participate in individual smoking cessation program
    Other Names:
  • Smoking and Tobacco Use Cessation Interventions

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Adaptation of the programmatic infrastructure of WebCASSI (Computer Assisted Stop Smoking Intervention for the World Wide Web) into a more-portable table and smartphone application (app) that will be available both in English and Spanish [Up to 5 weeks]

    2. Pre-testing of the app [Up to 5 weeks]

      A focus group will be used in order to provide feedback on the features of the app in relation to usability for smoking cessation and future app development.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Current smokers (those who smoke at least 5 cigarettes a day; confirmed with carbon monoxide (CO) levels equal or above 7 parts per million ) newly enrolled in the Tobacco Treatment Program at MDACC (Aim 2 )

    • Male or female (Aim 2)

    • Adult cancer patients - 18 years or older (Aim 2)

    • Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at Houston area community services who have smoked at least 100 cigarettes in lifetime

    • Willing to download and use the app Quitting Schedule (Aim 2)

    • Willing to set a quit smoking date within 5 weeks of the enrollment (Aim 2)

    • Ownership of an iPhone or Android smartphone (Aim 2)

    Exclusion Criteria:

    • Unwillingness to participate in the study (Aim 2)

    • Enrolled in another cessation program (Aim 2)

    • Current use of NRT or other smoking cessation medications,e.g. Varenicline or Bupropion outside of the MD Anderson Institution (Aim 2)

    • Expired CO levels below 7ppm (Aim 2)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 M D Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Paul Cinciripini, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT03668769
    Other Study ID Numbers:
    • 2016-0516
    • NCI-2018-01820
    • 2016-0516
    • P30CA016672
    First Posted:
    Sep 13, 2018
    Last Update Posted:
    Jun 30, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Neoplasms

    Study Results

    No Results Posted as of Jun 30, 2022